CMD BiobankBy creating a well characterized, central source of samples from individuals with CMDs, Cure CMD and Coriell are working together to facilitate CMD research and invest in the future of CMD therapies. The CMD BioBank will be housed in the National Institute of General Medical Sciences Human Genetic Cell Repository at the Coriell Institute. Samples in the NIGMS repository have been utilized in over 5,000 scientific publications by researchers in more than 50 countries.
Cure CMD will support the CMD BioBank by identifying and facilitating sample transfers from existing collections at other institutions. To provide scientists with a de-identified data set, CMD BioBank samples will be linked to existing profiles in the CMD International Registry through a code number. The CMDIR staff will provide: maximal motor function achieved, breathing status, concomitant medication use and CMD subtype verification. Having detailed information regarding clinical severity assists scientists using the CMD samples in understanding therapy response.
